Can Hemp Oil on Hair Produce Cannabinoid Results Without Proving Cannabis Use? A Nine-Person Analysis

Why a cannabinoid-positive hair test needs an exposure analysis

Hair is a different forensic specimen from blood, plasma, serum, urine, or oral fluid. Material may reach hair through systemic circulation during growth, through sweat or sebum, through deposition onto the hair surface, or through a combination of routes. Identification of a compound in a washed hair segment establishes an analytical finding in that prepared sample. It does not independently label the molecule’s route into the sample. External exposure is therefore not merely an alternative story about someone’s habits; it can be a scientifically relevant explanation that has to be tested against the analytical and circumstantial record.

The issue is particularly important where a result is offered in employment, professional discipline, family litigation, licensing, custody, or an injury dispute. Each setting may ask a different question: historical exposure, consumption, repeated use, an alleged time of use, or functional impairment at a particular event. Hair findings answer those questions with different degrees of confidence. The more specific the allegation, the greater the need to show that the method, the tested analytes, and the collection history support it.

What the original researchers actually did

The investigators enrolled ten adult volunteers, five women and five men. Volunteers stated that they had not used cannabis and were not knowingly exposed to it before the experiment. Each applied approximately 2 mL of the same commercially available hemp oil to the head hair in the evening, every day, for six weeks. Ordinary washing schedules were not standardized: most washed the following morning, while two occasionally kept the oil in place for an additional day or two. These details matter because product contact time and cosmetic habits are possible modifiers of residue and retention.

Hair was collected before treatment and again afterward. The researchers analyzed the scalp-proximal 0–3 cm segment, not a separately observed biological compartment circulating at the time of an incident. Their method included a methanol wash, sample digestion, extraction and clean-up, and gas chromatography with tandem mass spectrometry (GC–MS/MS). Analytes included THC, cannabidiol (CBD), cannabinol (CBN), 11-hydroxy-THC (THC-OH), and 11-nor-9-carboxy-THC (THC-COOH). Those names should not be conflated: the parent constituent and its metabolites have different interpretive significance.

One volunteer already had THC, CBD, and CBN in the pretreatment hair sample despite denying prior exposure. The authors removed that individual from the later comparison and interpretation, leaving nine evaluable volunteers. This exclusion is material. It prevents the simple, inaccurate description of the final percentages as outcomes in ten negative-at-baseline individuals, and it also shows that self-report and laboratory findings did not perfectly agree before the cosmetic intervention.

How many hair samples became cannabinoid-positive?

After six weeks, at least one measured cannabinoid appeared in eight of nine evaluable hair samples. The article’s rounded 89% figure is therefore 8/9, not 89 of 100 people and not a population prevalence estimate. Three of nine, or about 33%, had all three plant constituents THC, CBD, and CBN in the postapplication sample. Four participants had reported numerical THC concentrations, while other participants had CBD and/or CBN without reportable THC. One volunteer had no reportable analyte in the tested panel after treatment.

For forensic purposes, the detailed pattern matters more than a headline fraction. A single-positive CBN sample, a sample containing the three plant constituents together, and a sample containing an analytically confirmed human metabolite do not necessarily permit the same source attribution. Moreover, numbers this small cannot estimate what fraction of an unselected population using different brands, formulations, washing routines, hair types, or laboratories will have a positive result.

Which concentrations were measured, and in which matrix?

The hair values were reported in nanograms of analyte per milligram of hair (ng/mg). For example, the three volunteers who had THC, CBD, and CBN together had THC hair values of 0.13, 0.04, and 0.02 ng/mg. A different volunteer’s postapplication hair showed CBD at 3.26 ng/mg and CBN at 10.3 ng/mg without reportable THC; that person also had THC-OH at 0.01 ng/mg. Such figures are concentrations in a prepared solid keratin specimen, not concentrations of circulating cannabinoids in plasma or whole blood.

The selected cosmetic product was analyzed separately. CBN was quantified in the oil at 407 ng/mL; the investigators did not report confirmable THC, CBD, THC-OH, or THC-COOH in that product under their analysis. It would be wrong to treat 407 ng/mL of product as equivalent to any amount of CBN per milligram of hair. The media, extraction, analytical limits, and exposure mechanisms differ. Likewise, the absence of reportable THC in the tested oil cannot simply be turned into proof that every THC signal later identified in hair was caused by systemic cannabis consumption.

Why did some hair samples contain THC when the tested oil did not?

This discordance is a central limitation rather than an inconvenience to edit away. In the published discussion, the investigators considered whether cannabinoid-acid precursors in the oil might undergo transformation under some conditions, including sample preparation. They also described an unidentified signal near the THC channel that failed identification acceptance criteria. These are proposed explanations, not demonstrated chemical routes established by a separate precursor-speciation experiment in each volunteer.

Proper laboratory practice is to distinguish a chromatographic signal from a confirmed reportable identification. The authors expressly declined to label certain large but nonconforming peaks as THC. A retention-time resemblance by itself cannot substitute for all required identification criteria. This is exactly why chromatograms, ion-transition ratios, calibrator performance, blank and quality-control data, batch review, and a laboratory’s validated reporting rules matter when an individual result is contested. For a broader analytical framework, see the site’s confirmatory drug testing guide.

Does finding THC-OH prove the hemp oil caused that metabolite?

No. One volunteer had 0.01 ng/mg of THC-OH in postapplication hair. The authors treated that observation as anomalous and did not consider the oil alone a satisfactory explanation. THC-OH is a metabolite associated with physiological THC metabolism. Its presence therefore raises an interpretive question different from a hair finding limited to parent cannabinoids that may also exist in plant products or on surfaces. The investigators could not independently exclude undocumented cannabis exposure or consumption in that participant.

It would also be too strong to claim that this single result conclusively reconstructs when or how THC was used. The study did not continuously observe participants’ private environments or verify their reports by serial systemic testing throughout six weeks. It used one product, a small group, and a limited sampling schedule. In contested testimony, the correct description is that a potentially more consumption-informative analyte appeared in one hair sample, with its specific source not resolved by this experiment.

Why absence of THC-COOH is important but not conclusive

THC-COOH is a downstream metabolite often used to strengthen an interpretation that THC entered the body rather than merely contacted hair externally. The researchers reported no THC-COOH among these nine evaluable postapplication samples. That negative finding is relevant to the limited proposition the experiment was designed to investigate: plant cannabinoids can become detectable in hair after cosmetic treatment even when the particular metabolite measured was not detected. It is not a validated rule that every external exposure produces THC-COOH negativity or that every person who ingests cannabis must have detectable hair THC-COOH.

Negative results depend on the analyte tested, extraction recovery, laboratory sensitivity, sample segment, timing, and reporting threshold. Not detected means the procedure did not establish the analyte at its applicable decision level, not that no molecule could possibly have been present in all places and at all times. Conversely, a reportable metabolite finding calls for matrix-specific interpretation and examination of possible alternative sources and artifacts, not a reflex assumption about impairment.

What does washing the hair prove about contamination?

The experiment included a laboratory methanol wash before the remaining preparation and GC–MS/MS analysis. Nevertheless, some postapplication hair samples contained reportable cannabinoids. It follows that an analyte surviving a particular wash is not, on this experimental evidence alone, proof that the analyte arrived exclusively through circulation. The wash is a sample-processing intervention; it is not a universal biological source-tagging test. A different laboratory’s wash solvents, times, wash fractions, acceptance rules, and extraction chemistry may produce a different analytical profile.

In a litigated hair case, the requested records should include the complete wash protocol, the disposition and measurement of wash fractions when available, an assessment of hair surface treatments, and the analytical method’s contamination challenges. A laboratory that reports a washed hair result may be methodologically sound while still having insufficient evidence to say whether deposition was external or systemic. Those are different levels of scientific assertion.

Hair segment length cannot precisely identify a day of use

Here the tested 0–3 cm hair section was sampled after six weeks of near-daily oil exposure. A proximal segment is not a clock with a guaranteed growth rate for each strand. Hair growth, collection orientation, cosmetic handling, differences along shafts, diffusion, washing, and external deposition can blur time attribution. Even if a laboratory produces segment-by-segment concentrations, a specific calendar date generally requires assumptions and supporting information beyond the analytic result itself.

For a worker, parent, licensee, or defendant, statements such as “the individual used cannabis on a particular weekend” go beyond the experiment. Nor can this study determine the pharmacological dose, frequency of systemic use, route of exposure, or whether cannabis was consumed before a specified event. The interpretation should remain tied to the actual biological matrix and its limitations, rather than translating hair concentration into an imagined blood concentration or behavioral state.

External contamination, actual use, and impairment are three different questions

Analytical confirmation concerns whether the specified chemical was present in the laboratory-prepared specimen at a reportable level. Source attribution concerns how that chemical reached the sampled hair, including possible contact with cosmetic oils, smoke, handling, sweat, or deposition from systemic use. Functional impairment concerns the person’s abilities at an event. A hair result does not collapse these into one inference. The Paul study did not assay contemporary venous whole blood, serum, plasma, breath, or oral fluid, and did not administer standardized driving, coordination, decision-making, memory, or psychomotor tests.

It would therefore be unsupported to calculate a blood THC concentration, an oral THC dose, a BrAC/BAC equivalent, a number of cannabis-smoking sessions, or individual intoxication from these hair data. Statistical proportions from nine people also cannot establish personal causation in a specific case. If a separate blood or oral-fluid result exists, it should be interpreted with its own collection time, tested metabolites, confirmation procedures, and uncertainty; its meaning cannot be manufactured retroactively by borrowing these hair percentages.

What was controlled, and what was not?

The experimental exposure was specific: a single marketed hemp-oil product was applied repeatedly, in approximately similar daily quantity, by ten self-selected volunteers who completed baseline and follow-up sampling. The researchers documented the analytical platform and identified one pretreatment-positive participant. These features make the paper useful as a demonstration of a plausible confounder in hair analysis. But the study was not a large randomized controlled trial of cosmetics against a nonexposed group, and it did not blind participants to what was applied.

The oil composition, regularity of contact, washing habits, hair properties, assay chemistry, environmental background, and actual pre-study consumption history were not exhaustively controlled. The study did not compare many commercial oils or independently verify every ingredient, possible cannabinoid precursor, or transformation product. Two volunteers sometimes left oil on longer, which may have influenced their high CBD/CBN hair values. Those observations generate testable hypotheses; they are not controlled proof that contact duration alone explains the concentration differences.

Two distinct evidence questions a report must not merge

What source records should be requested in a contested hair test?

Start with the actual sampled segment and the question the lab was authorized to answer. A meaningful review may require chain-of-custody documentation, date and location of collection, strand orientation, measured segment lengths, hair-color and treatment history, sample wash and digestion records, calibration and QC evidence, precursor or metabolite panel, extracted-ion chromatograms and acceptance criteria, instrument data, and the laboratory’s interpretation policy. If the subject reports hemp-oil use, ask for product brand, batch, packaging, photograph, application frequency, other hair products, and any retained product for independently defensible testing.

These requests are investigative steps, not proof that a particular person’s claim of cosmetic application is true. Likewise, a denial of cannabis use is evidence of what the person reported, not a substitute for verification. A laboratory may confirm the chemistry of hair and still be unable to adjudicate the credibility of competing exposure histories. The site’s specimen-collection guide explains why provenance, timing, and handling must be considered with the assay.

Frequently asked questions about topical hemp oil and hair THC

Can hemp oil applied to hair produce a reportable THC result?

In this study, four of nine evaluable postapplication hair samples contained reportable THC, and three contained THC, CBD, and CBN together. The product itself was not reported positive for THC under the method, so the exact mechanism for every THC signal was unresolved; the result does not establish a universal incidence across products.

Did 89% of everyone enrolled test positive?

No. Ten people enrolled, but one already had cannabinoids in hair before the intervention and was excluded from the comparison. The quoted 89% is eight of the nine evaluable participants. The study was too small to generalize this fraction to ordinary cosmetic users.

Does a confirmed hair THC result establish smoking or ingestion?

Not by itself. Confirmed identity in the tested hair matrix and a conclusion about how THC reached the hair are distinct. An admissible source opinion depends on the full metabolite profile, specimen preparation, exposure history, product testing, and other case evidence.

What does a hair THC-COOH negative result mean?

The tested specimen did not yield reportable THC-COOH under that method. No postapplication specimen in this small series had it. Negative results cannot universally exclude cannabis use because analytical sensitivity, incorporation, and timing vary; a finding still must be considered in context.

What about the one sample containing THC-OH?

That finding is a material exception: the original authors did not establish cosmetic formation as its cause and could not rule out unreported exposure. It should not be erased from a defense analysis or misrepresented as definitive proof of a particular route or date of use.

Does the study establish that a particular person was intoxicated?

No. This was a hair-cosmetic exposure study, not a driving, behavior, medical intoxication, or blood pharmacokinetic study. It measured compounds in proximal head-hair samples. It provides no validated calculation from ng/mg hair to circulating cannabinoid concentration or individual impairment.

Will a routine hair wash remove all external cannabinoid contamination?

There is no such conclusion from this experiment. Reportable findings remained after the published methanol washing and extraction protocol. The efficacy and meaning of decontamination require method-specific validation and inspection of actual raw laboratory data; a wash step is not a universal proof of source.

Primary source and defensible conclusion

Paul R, Williams R, Hodson V, Peake C. Detection of cannabinoids in hair after cosmetic application of hemp oil. Scientific Reports. 2019;9:2582. DOI: 10.1038/s41598-019-39609-0.

Bounded conclusion: Repeated topical treatment with one hemp oil was followed by detectable cannabinoids in most evaluable hair samples of a very small cohort. The study demonstrates a concrete challenge to treating hair detection of plant cannabinoids as automatic proof of cannabis ingestion. It does not resolve each participant’s exposure source, assign a consumption date, validate a universal detection rate, or connect an individual hair result to legally relevant impairment or causation. Any case opinion must separately test the specimen’s analytical identity, the source attribution, and the event-level inference.